drugset / Trial / NCT01776619

Safety and Tolerability Study of Multiple Doses of PF-06305591

NCT01776619

Phase 1 Completed 43 enrolled Pfizer
RandomizedParallel-groupDouble-blindBasic science

Summary

Safety, tolerability and PK of repeated doses of PF-06305591 will be evaluated in young healthy volunteers toghether with food effect on relative bioavailability of solid formulation after single dose.

Timeline

Start
2013-04
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-06305591 Small molecule 20 mg
Subject PF-06305591 Small molecule 40 mg
Subject PF-06305591 Small molecule 50 mg
Subject PF-06305591 Small molecule 80 mg

Indications

No indication recorded.